1.A Novel Technical Approach for Infant Thyroidectomies in Twins With MEN2B (M918T RET Codon) Highest Risk Mutations
Timothy GREER ; Gideon SANDLER ; Paul BENITEZ-AGUIRRE ; Jennifer CHIEN ; Catherine LANGUSCH
Journal of Endocrine Surgery 2024;24(4):135-140
The RET oncogene plays an important role in multiple endocrine neoplasia (MEN) type 2B and the development of medullary thyroid cancer. Highest risk amongst these RET codon mutations is M918T. Most cases of MEN type 2B are detected de novo later in childhood, however there remain instances of parental inheritance. When parenteral inheritance of a M918T mutation is confirmed after birth current guidelines recommend a prophylactic thyroidectomy in infancy. We report a case of twin boys born to a 31-yearold female with known MEN2B RET codon M918T mutation. Both boys had confirmatory testing for the M918T mutation after birth. After pre-operative investigations revealed sonographically normal thyroids, no cervical lymphadenopathy and normal calcitonin levels they both underwent prophylactic thyroidectomy at 7 months corrected gestational age. Thyroidectomies in infancy offer unique challenges including translucent parathyroid glands and airways too narrow to accommodate a standard Neural Integrity Monitor (NIM) endotracheal tube. We describe our surgical technique for an infant total thyroidectomy and fashioning of a novel NIM tube to allow for recurrent laryngeal nerve (RLN) monitoring to minimise complications in these very young patients. Both infants made a complete recovery without any significant complication. Histopathology revealed evidence of focal C Cell hyperplasia, but no malignancy in either thyroid gland. Our experience with these 2 cases highlights the importance of an experienced multidisciplinary team in infant thyroidectomies and outlines a novel technique to allow for RLN monitoring intraoperatively.
2.Academy of Medicine-Ministry of Health clinical practice guidelines: attention deficit hyperactivity disorder.
Daniel S S FUNG ; Choon Guan LIM ; John Chee Meng WONG ; Koon Hock NG ; Christopher Cheng Soon CHEOK ; Jennifer Sie Hee KIING ; Shang Chee CHONG ; June LOU ; Mary Lourdes DANIEL ; Desmond ONG ; Charity LOW ; Sharifah Mariam ALJUNIED ; Pui Meng CHOI ; Kala MEHROTRA ; Carolyn KEE ; Ivy LEUNG ; Lee Chen YEN ; Geraldine WONG ; Poh Yin LEE ; Bella CHIN ; Hwee Chien NG
Singapore medical journal 2014;55(8):411-quiz 415
The Academy of Medicine (AMS) and the Ministry of Health (MOH) have developed the clinical practice guidelines on Attention Deficit Hyperactivity Disorder (ADHD) to provide doctors and patients in Singapore with evidence-based treatment for ADHD. This article reproduces the introduction and executive summary (with recommendations from the guidelines) from the MOH clinical practice guidelines on ADHD, for the information of SMJ readers. Chapters and page numbers mentioned in the reproduced extract refer to the full text of the guidelines, which are available from the Ministry of Health website: http://www.moh.gov.sg/content/moh_web/healthprofessionalsportal/doctors/guidelines/cpg_medical.html.The recommendations should be used with reference to the full text of the guidelines. Following this article are multiple choice questions based on the full text of the guidelines.
Attention Deficit Disorder with Hyperactivity
;
diagnosis
;
drug therapy
;
therapy
;
Caregivers
;
Child
;
Evidence-Based Medicine
;
Humans
;
Methylphenidate
;
therapeutic use
;
Parents
;
Psychiatry
;
methods
;
standards
;
Singapore
;
Societies, Medical

Result Analysis
Print
Save
E-mail